PPMD Convenes Global Community in Orlando to Tackle Duchenne and Becker

The conference, which runs June 25–27, marks a significant milestone in the organization's three-decade history. CEO Katherine Beaverson emphasized that the event provides a critical space for stakeholders to navigate the recent breakthroughs and setbacks in the field. The agenda is built around multi-dimensional care, with specific tracks dedicated to the lived experience of patients, including sessions for newly diagnosed families, teens, and siblings.

Technical discussions will span the latest in exon-skipping approaches and the future of gene therapy, alongside essential guidance on transition planning and mental health. The programming also addresses specific needs for the Becker community and provides direct access to specialists through one-on-one appointments with physical therapists and genetic experts. Beyond clinical sessions, the event emphasizes community building, featuring a resource fair and social gatherings designed to foster connections among those affected by these neuromuscular conditions. The conference is supported by a wide array of industry partners, including elite sponsors Capricor Therapeutics and Sarepta Therapeutics.